Log In
Print this Print this

Evenamide (NW-3509)

  Manage Alerts
Collapse Summary General Information
Company Newron Pharmaceuticals S.p.A.
DescriptionVoltage-gated sodium channel inhibitor
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today